R M Liskamp - JoVE Visualize

Showing results (21-30 of 36) with videos related to

Pageof 4

Sort By:

Biochemical and Biophysical Research Communications|September 16, 1985

Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promotersR M Liskamp, A R Brothman, J P Arcoleo, et al.

Bioorganic & Medicinal Chemistry Letters|June 20, 2001

Bio-inspired synthetic receptor molecules towards mimicry of vancomycinM C Monnee, A J Brouwer, L M Verbeek, et al.

Rapid Communications in Mass Spectrometry : RCM|January 1, 1996

Comparing mass spectrometric characteristics of peptides and peptoidsW Heerma, C Versluis, C G de Koster, et al.

Biochemical Pharmacology|January 1, 1990

N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitorC A O'Brian, N E Ward, R M Liskamp, et al.

Journal of Chromatography|June 10, 1983

Determination of sparsomycin in plasma and urine of the dog by means of reversed-phase high-performance liquid chromatography and first pharmacokinetic resultsB Winograd, M J Oosterbaan, E van der Kleijn, et al.

International Journal of Peptide and Protein Research|February 1, 1989

Synthesis of a substrate of protein kinase C and its corresponding phosphopeptideH B de Bont, R M Liskamp, C A O'Brian, et al.

The Journal of Biological Chemistry|September 5, 1993

Inhibition of neutrophil NADPH oxidase assembly by a myristoylated pseudosubstrate of protein kinase CA J Verhoeven, J H Leusen, G C Kessels, et al.

Chembiochem : a European Journal of Chemical Biology|April 12, 2002

Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugatesS André, R J Pieters, I Vrasidas, et al.

Investigational New Drugs|May 1, 1991

A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycinC A O'Brian, N E Ward, R M Liskamp, et al.

Journal of Medicinal Chemistry|February 1, 1987

Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growthL A van den Broek, R M Liskamp, J H Colstee, et al.

Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:

Pageof 4

Biochemical and Biophysical Research Communications|September 16, 1985

Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promotersR M Liskamp, A R Brothman, J P Arcoleo, et al.

Bioorganic & Medicinal Chemistry Letters|June 20, 2001

Bio-inspired synthetic receptor molecules towards mimicry of vancomycinM C Monnee, A J Brouwer, L M Verbeek, et al.

Rapid Communications in Mass Spectrometry : RCM|January 1, 1996

Comparing mass spectrometric characteristics of peptides and peptoidsW Heerma, C Versluis, C G de Koster, et al.

Biochemical Pharmacology|January 1, 1990

N-myristyl-Lys-Arg-Thr-Leu-Arg: a novel protein kinase C inhibitorC A O'Brian, N E Ward, R M Liskamp, et al.

Journal of Chromatography|June 10, 1983

Determination of sparsomycin in plasma and urine of the dog by means of reversed-phase high-performance liquid chromatography and first pharmacokinetic resultsB Winograd, M J Oosterbaan, E van der Kleijn, et al.

International Journal of Peptide and Protein Research|February 1, 1989

Synthesis of a substrate of protein kinase C and its corresponding phosphopeptideH B de Bont, R M Liskamp, C A O'Brian, et al.

The Journal of Biological Chemistry|September 5, 1993

Inhibition of neutrophil NADPH oxidase assembly by a myristoylated pseudosubstrate of protein kinase CA J Verhoeven, J H Leusen, G C Kessels, et al.

Chembiochem : a European Journal of Chemical Biology|April 12, 2002

Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugatesS André, R J Pieters, I Vrasidas, et al.

Investigational New Drugs|May 1, 1991

A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycinC A O'Brian, N E Ward, R M Liskamp, et al.

Journal of Medicinal Chemistry|February 1, 1987

Structure-activity relationships of sparsomycin and its analogues. Inhibition of peptide bond formation in cell-free systems and of L1210 and bacterial cell growthL A van den Broek, R M Liskamp, J H Colstee, et al.

Pageof 4